Atlas Trials

Open-Label Extension of Other SZ1839 (Iressa) Trials

Clinical trial NCT00635973 · COMPLETED

Trial details

NCT number
NCT00635973
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cancer
Start date
2000-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.